Annual accounts receivable:
$6.78B-$486.00M(-6.69%)Summary
- As of today (May 23, 2025), AMGN annual accounts receivable is $6.78 billion, with the most recent change of -$486.00 million (-6.69%) on December 31, 2024.
- During the last 3 years, AMGN annual accounts receivable has risen by +$1.89 billion (+38.55%).
- AMGN annual accounts receivable is now -6.69% below its all-time high of $7.27 billion, reached on December 31, 2023.
Performance
AMGN Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$8.13B+$1.35B(+19.91%)Summary
- As of today (May 23, 2025), AMGN quarterly accounts receivable is $8.13 billion, with the most recent change of +$1.35 billion (+19.91%) on March 31, 2025.
- Over the past year, AMGN quarterly accounts receivable has increased by +$1.36 billion (+20.01%).
- AMGN quarterly accounts receivable is now at all-time high.
Performance
AMGN Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
AMGN Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.7% | +20.0% |
| 3 y3 years | +38.5% | +60.2% |
| 5 y5 years | +67.2% | +62.4% |
AMGN Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.7% | +38.5% | at high | +60.2% |
| 5 y | 5-year | -6.7% | +67.2% | at high | +98.6% |
| alltime | all time | -6.7% | +1642.5% | at high | +2054.2% |
AMGN Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $8.13B(+19.9%) |
| Dec 2024 | $6.78B(-6.7%) | $6.78B(-7.3%) |
| Sep 2024 | - | $7.32B(+5.5%) |
| Jun 2024 | - | $6.93B(+2.3%) |
| Mar 2024 | - | $6.78B(-6.8%) |
| Dec 2023 | $7.27B(+30.6%) | $7.27B(+18.3%) |
| Sep 2023 | - | $6.14B(+5.4%) |
| Jun 2023 | - | $5.83B(+1.6%) |
| Mar 2023 | - | $5.74B(+3.1%) |
| Dec 2022 | $5.56B(+13.6%) | $5.56B(+4.4%) |
| Sep 2022 | - | $5.33B(-0.0%) |
| Jun 2022 | - | $5.33B(+4.9%) |
| Mar 2022 | - | $5.08B(+3.7%) |
| Dec 2021 | $4.89B(+8.2%) | $4.89B(+2.7%) |
| Sep 2021 | - | $4.76B(+6.4%) |
| Jun 2021 | - | $4.48B(+1.3%) |
| Mar 2021 | - | $4.42B(-2.3%) |
| Dec 2020 | $4.53B(+11.5%) | $4.53B(+10.5%) |
| Sep 2020 | - | $4.09B(-23.7%) |
| Jun 2020 | - | $5.37B(+7.1%) |
| Mar 2020 | - | $5.01B(+23.5%) |
| Dec 2019 | $4.06B(+13.3%) | $4.06B(+12.5%) |
| Sep 2019 | - | $3.61B(-5.1%) |
| Jun 2019 | - | $3.80B(+0.8%) |
| Mar 2019 | - | $3.77B(+5.3%) |
| Dec 2018 | $3.58B(+10.6%) | $3.58B(+4.0%) |
| Sep 2018 | - | $3.44B(-1.8%) |
| Jun 2018 | - | $3.50B(-3.6%) |
| Mar 2018 | - | $3.63B(+12.2%) |
| Dec 2017 | $3.24B(+2.3%) | $3.24B(-4.9%) |
| Sep 2017 | - | $3.40B(-4.4%) |
| Jun 2017 | - | $3.56B(+9.6%) |
| Mar 2017 | - | $3.25B(+2.6%) |
| Dec 2016 | $3.17B(+5.7%) | $3.17B(-0.7%) |
| Sep 2016 | - | $3.19B(+3.5%) |
| Jun 2016 | - | $3.08B(0.0%) |
| Mar 2016 | - | $3.08B(+2.8%) |
| Dec 2015 | $3.00B(+17.6%) | $3.00B(+3.2%) |
| Sep 2015 | - | $2.90B(+4.4%) |
| Jun 2015 | - | $2.78B(+9.1%) |
| Mar 2015 | - | $2.55B(+0.1%) |
| Dec 2014 | $2.55B(-5.6%) | $2.55B(+8.1%) |
| Sep 2014 | - | $2.35B(-12.7%) |
| Jun 2014 | - | $2.70B(+7.3%) |
| Mar 2014 | - | $2.51B(-6.8%) |
| Dec 2013 | $2.70B | $2.70B(+1.0%) |
| Sep 2013 | - | $2.67B(-0.1%) |
| Jun 2013 | - | $2.67B(+5.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | $2.53B(+0.4%) |
| Dec 2012 | $2.52B(-13.1%) | $2.52B(-6.6%) |
| Sep 2012 | - | $2.70B(-0.4%) |
| Jun 2012 | - | $2.71B(-9.4%) |
| Mar 2012 | - | $2.99B(+3.2%) |
| Dec 2011 | $2.90B(+24.0%) | $2.90B(+6.3%) |
| Sep 2011 | - | $2.73B(+0.4%) |
| Jun 2011 | - | $2.71B(+7.8%) |
| Mar 2011 | - | $2.52B(+7.8%) |
| Dec 2010 | $2.33B(+10.7%) | $2.33B(+5.8%) |
| Jun 2010 | - | $2.21B(-2.8%) |
| Mar 2010 | - | $2.27B(+7.7%) |
| Dec 2009 | $2.11B(+1.7%) | $2.11B(-9.5%) |
| Sep 2009 | - | $2.33B(+6.8%) |
| Jun 2009 | - | $2.18B(+8.6%) |
| Mar 2009 | - | $2.01B(-3.1%) |
| Dec 2008 | $2.07B(-1.3%) | $2.07B(-1.9%) |
| Sep 2008 | - | $2.11B(-9.3%) |
| Jun 2008 | - | $2.33B(+4.8%) |
| Mar 2008 | - | $2.22B(+5.9%) |
| Dec 2007 | $2.10B(-1.1%) | $2.10B(-2.5%) |
| Sep 2007 | - | $2.15B(-0.4%) |
| Jun 2007 | - | $2.16B(+0.3%) |
| Mar 2007 | - | $2.16B(+1.6%) |
| Dec 2006 | $2.12B(+20.1%) | $2.12B(0.0%) |
| Sep 2006 | - | $2.12B(+5.3%) |
| Jun 2006 | - | $2.02B(+12.5%) |
| Mar 2006 | - | $1.79B(+1.4%) |
| Dec 2005 | $1.77B(+21.1%) | $1.77B(+6.3%) |
| Sep 2005 | - | $1.66B(-2.5%) |
| Jun 2005 | - | $1.71B(+7.8%) |
| Mar 2005 | - | $1.58B(+8.4%) |
| Dec 2004 | $1.46B(+44.9%) | $1.46B(+3.4%) |
| Sep 2004 | - | $1.41B(+10.3%) |
| Jun 2004 | - | $1.28B(+7.2%) |
| Mar 2004 | - | $1.20B(+18.6%) |
| Dec 2003 | $1.01B(+34.0%) | $1.01B(+0.7%) |
| Sep 2003 | - | $1.00B(+4.2%) |
| Jun 2003 | - | $960.70M(+13.7%) |
| Mar 2003 | - | $845.20M(+12.4%) |
| Dec 2002 | $752.00M(+51.2%) | $752.00M(+20.9%) |
| Sep 2002 | - | $622.20M(+12.4%) |
| Jun 2002 | - | $553.50M(+5.4%) |
| Mar 2002 | - | $525.10M(+5.6%) |
| Dec 2001 | $497.20M(+27.7%) | $497.20M(+3.3%) |
| Sep 2001 | - | $481.50M(+27.5%) |
| Jun 2001 | - | $377.50M(-12.6%) |
| Mar 2001 | - | $431.70M(+10.9%) |
| Dec 2000 | $389.20M | $389.20M |
FAQ
- What is Amgen annual accounts receivable?
- What is the all time high annual accounts receivable for Amgen?
- What is Amgen annual accounts receivable year-on-year change?
- What is Amgen quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Amgen?
- What is Amgen quarterly accounts receivable year-on-year change?
What is Amgen annual accounts receivable?
The current annual accounts receivable of AMGN is $6.78B
What is the all time high annual accounts receivable for Amgen?
Amgen all-time high annual accounts receivable is $7.27B
What is Amgen annual accounts receivable year-on-year change?
Over the past year, AMGN annual accounts receivable has changed by -$486.00M (-6.69%)
What is Amgen quarterly accounts receivable?
The current quarterly accounts receivable of AMGN is $8.13B
What is the all time high quarterly accounts receivable for Amgen?
Amgen all-time high quarterly accounts receivable is $8.13B
What is Amgen quarterly accounts receivable year-on-year change?
Over the past year, AMGN quarterly accounts receivable has changed by +$1.36B (+20.01%)